These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
194 related articles for article (PubMed ID: 26573220)
1. Comparative efficacy of esomeprazole and omeprazole: Racemate to single enantiomer switch. Asghar W; Pittman E; Jamali F Daru; 2015 Nov; 23():50. PubMed ID: 26573220 [TBL] [Abstract][Full Text] [Related]
2. Meta-analysis of the effectiveness of esomeprazole in gastroesophageal reflux disease and Helicobacter pylori infection. Teng M; Khoo AL; Zhao YJ; Lin L; Lim BP; Wu TS; Dan YY J Clin Pharm Ther; 2015 Aug; 40(4):368-75. PubMed ID: 25893507 [TBL] [Abstract][Full Text] [Related]
3. Comparative effectiveness and tolerability of esomeprazole and omeprazole in gastro-esophageal reflux disease: A systematic review and meta-analysis. Qi Q; Wang R; Liu L; Zhao F; Wang S Int J Clin Pharmacol Ther; 2015 Oct; 53(10):803-10. PubMed ID: 26329348 [TBL] [Abstract][Full Text] [Related]
4. [Pharma clinics medication of the month. Esomeprazole]. Louis E Rev Med Liege; 2002 Sep; 57(9):610-2. PubMed ID: 12440351 [TBL] [Abstract][Full Text] [Related]
5. Esomeprazole 40 mg provides more effective intragastric acid control than lansoprazole 30 mg, omeprazole 20 mg, pantoprazole 40 mg and rabeprazole 20 mg in patients with gastro-oesophageal reflux symptoms. Röhss K; Lind T; Wilder-Smith C Eur J Clin Pharmacol; 2004 Oct; 60(8):531-9. PubMed ID: 15349707 [TBL] [Abstract][Full Text] [Related]
6. Single enantiomer versus racemate: chiral distinction in the proton pump inhibitors omeprazole and esomeprazole. Marom H; Pogodin S; Agranat I Chirality; 2014 Apr; 26(4):214-27. PubMed ID: 24619931 [TBL] [Abstract][Full Text] [Related]
7. Indirect comparison of randomised controlled trials: comparative efficacy of dexlansoprazole vs. esomeprazole in the treatment of gastro-oesophageal reflux disease. Wu MS; Tan SC; Xiong T Aliment Pharmacol Ther; 2013 Jul; 38(2):190-201. PubMed ID: 23718547 [TBL] [Abstract][Full Text] [Related]
8. Esomeprazole provides improved acid control vs. omeprazole In patients with symptoms of gastro-oesophageal reflux disease. Lind T; Rydberg L; Kylebäck A; Jonsson A; Andersson T; Hasselgren G; Holmberg J; Röhss K Aliment Pharmacol Ther; 2000 Jul; 14(7):861-7. PubMed ID: 10886041 [TBL] [Abstract][Full Text] [Related]
12. Effect of CYP2C19 genetic polymorphisms on the efficacy of proton pump inhibitor-based triple therapy for Helicobacter pylori eradication: a meta-analysis. Zhao F; Wang J; Yang Y; Wang X; Shi R; Xu Z; Huang Z; Zhang G Helicobacter; 2008 Dec; 13(6):532-41. PubMed ID: 19166419 [TBL] [Abstract][Full Text] [Related]
13. Esomeprazole: a clinical review. Johnson TJ; Hedge DD Am J Health Syst Pharm; 2002 Jul; 59(14):1333-9. PubMed ID: 12132559 [TBL] [Abstract][Full Text] [Related]
20. A meta-analysis: comparison of esomeprazole and other proton pump inhibitors in eradicating Helicobacter pylori. Wang X; Fang JY; Lu R; Sun DF Digestion; 2006; 73(2-3):178-86. PubMed ID: 16837803 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]